MapLight Therapeutics (MPLT) PT Raised to $52 at UBS on Enhanced Sales Outlook
Tweet Send to a Friend
(Updated - July 21, 2026 8:42 AM EDT)
UBS analyst Ashwani Verma raised the price target on MapLight Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma raised the price target on MapLight Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
